3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
9
Breast Neoplasms
9
Obesity
6
Motor Activity
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Overweight
4
Malnutrition
4
Hypertension
4
Stroke
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Heart Failure
3
Diabetes Mellitus
3
Cardiovascular Diseases
3
Sarcopenia
2
Polycystic Ovary Syndrome
2
Osteoporosis
2
Kidney Diseases
2
Heart Diseases
2
Frailty
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Arthritis
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thinness
1
Solid Tumors
1
Interventions
Surveys and Questionnaires
9
Standard of Care
5
Endoscopic Mucosal Resection
5
Educational Status
5
Blood Specimen Collection
5
Diet Therapy
3
Referral and Consultation
2
Quality of Life
2
Practice Guidelines as Topic
2
Palliative Care
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Control Groups
2
Aprepitant
2
Acceptance and Commitment Therapy
2
vandetanib
1
fosaprepitant
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Weights and Measures
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surgical Instruments
1
Sunitinib
1
Sorafenib
1
Sampling Studies
1
Restraint, Physical
1
Remote Patient Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Gastrointestinal Neoplasms
×
Nutrition Assessment
×
Clear all
NCT03670199
2021-09-13
PENDICOQ
University Hospital, Strasbourg, France
Phase NA
Unknown
200 enrolled